Type 2 & other diabetes

Cost-Effective Quality of Life Improvement While Reducing Health Care Professional Burnout With an AI-Driven Intervention for Personalized Medicine

J Diabetes Sci TechnolPublished Within-trial cost-effectiveness analysis of a randomised controlled trial

Authors' conclusion

Spotlight-AQ has demonstrated cost-effective while delivering improved care and reduced HCP burnout.

Study context

Population
Adults with diabetes recruited from primary and secondary care; 18 health care professional (HCPs)plus 18 HCPs
Participants
98 adults
Comparison
Spotlight-AQ pre-clinic assessment vs usual care
  • Spotlight-AQn = 49
Methodological detailscomplete case, multicentre, parallel-group
  • Complete case
  • Multicentre
  • Parallel-group

Primary result

As reported in the abstract

Cost-effectiveness: total costs and QALYs (within-trial, complete case)
Total costs, intervention arm vs control arm
£243 (US$310) vs £230 (US$293)
Incremental cost
£13 (US$16)
Total quality-adjusted life years (QALYs), intervention arm vs control arm
0.362 vs 0.358
Incremental QALY
0.004
Spotlight-AQ dominated usual care; probability of cost-effectiveness at £30 000 (US$38 294) per QALY gained
68%

Further findings

HCP burnout (Maslach Burnout Inventory) · baseline to study end

HCPs reported reduced burnout, emotional exhaustion, depersonalization and greater sense of personal achievement; doctors more so than nurses

Original publication

Cost-Effective Quality of Life Improvement While Reducing Health Care Professional Burnout With an AI-Driven Intervention for Personalized Medicine. J Diabetes Sci Technol. Published 30 January 2025. doi:10.1177/19322968241310879

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.